Search

everythinglearnresearchcommunity

for

Search:↓

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Platelet-rich plasma infusion improved pregnancy outcomes for women with thin endometrium.

Thyroid issues can cause alopecia areata.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Insulin therapy helped a man with autoimmune issues regrow his hair.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

High levels of androgens during early development may cause PCOS-like symptoms.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Doctors need to be better prepared to assess and treat obesity in patients.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Finasteride and metformin both help treat PCOS, but using them together works best.